Literature DB >> 18367565

Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007.

Philippe André1, Valerie Caro, Elisabeth Njamkepo, Aaron M Wendelboe, Annelies Van Rie, Nicole Guiso.   

Abstract

Bacterial culture for diagnosing pertussis infection has high specificity but poor sensitivity and is slow. Highly sensitive real-time PCR assays and single-serum pertussis serology have been developed to overcome these limitations, but there are few data available on the relative sensitivities and specificities of such assays for pertussis diagnosis. Using data on 195 participants (>or=7 years old) from an epidemiological study, we assessed the sensitivity, specificity, and performance (Youden index) for pertussis diagnosis of the pertussis toxin enzyme-linked immunosorbent assay (using single and paired serology) and of real-time PCR assays (using the IS481 and ptxA-Pr targets). All available diagnostic information (clinical and laboratory) was pooled to serve as the gold standard. Single serology was the most efficient diagnostic test (Youden index, 0.57 to 0.58), with relatively high sensitivity (>64%) and high specificity (>90%), independent of the cutoff level. IS481 PCR performance was superior to that of ptxA-Pr PCR, and it was the second-most-efficient tool (Youden index, 0.30). Performing both ptxA-Pr and IS481 PCRs did not improve diagnostic performance. The greatest test efficiency (Youden index, 0.69 to 0.74) was achieved when single-serum serology was used in combination with IS481 or ptxA-Pr PCR or paired serology. Combining single serology with one PCR or paired serology increased the sensitivity with an associated limited decrease in specificity. The most specific tests for diagnosis of pertussis were single serology and ptxA-Pr PCR, and the most sensitive diagnostic tool was the combination of IS481 PCR with single serology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367565      PMCID: PMC2395107          DOI: 10.1128/JCM.02187-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology.

Authors:  F R Mooi; H Hallander; C H Wirsing von König; B Hoet; N Guiso
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-03       Impact factor: 3.267

2.  Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.

Authors:  C Weber; C Boursaux-Eude; G Coralie; V Caro; N Guiso
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains.

Authors:  Natacha Kourova; Valérie Caro; Christian Weber; Sabine Thiberge; Raisa Chuprinina; Galina Tseneva; Nicole Guiso
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

4.  Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.

Authors:  Andrew L Baughman; Kristine M Bisgard; Kathryn M Edwards; Dalya Guris; Michael D Decker; Kathy Holland; Bruce D Meade; Freyja Lynn
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

5.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

6.  Bias in discrepant analysis: when two wrongs don't make a right.

Authors:  W C Miller
Journal:  J Clin Epidemiol       Date:  1998-03       Impact factor: 6.437

7.  A comparison of enzyme immunoassays used to measure serum antibodies to components of Bordetella pertussis.

Authors:  F Lynn; G F Reed; B D Meade
Journal:  Dev Biol Stand       Date:  1997

8.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

Authors:  R M Horton; H D Hunt; S N Ho; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

9.  Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal.

Authors:  F Simondon; I Iteman; M P Preziosi; A Yam; N Guiso
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

10.  Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species.

Authors:  N Khelef; B Danve; M J Quentin-Millet; N Guiso
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

View more
  27 in total

1.  Seroprevalence of pertussis among Danish patients with cough of unknown etiology.

Authors:  Tine Dalby; Zitta B Harboe; Karen Angeliki Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

2.  Significant finding of Bordetella holmesii DNA in nasopharyngeal samples from French patients with suspected pertussis.

Authors:  Elisabeth Njamkepo; Stéphane Bonacorsi; Monique Debruyne; Sophie Anne Gibaud; Sophie Guillot; Nicole Guiso
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

3.  Pertussis in Florida, 2000-2006: trends in a historically low-incidence state.

Authors:  Joann M Schulte; Robyn Kay; Janet J Hamilton; Cathy Mellinger; Phyllis Yambor; Christie Luce; Dawn Ginzl; Julia Gill; Richard S Hopkins
Journal:  Public Health Rep       Date:  2010 Sep-Oct       Impact factor: 2.792

4.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

5.  Proficiency program for real-time PCR diagnosis of Bordetella pertussis infections in French hospital laboratories and at the French National Reference Center for Whooping Cough and other Bordetelloses.

Authors:  Valérie Caro; Nicole Guiso; Corinne Alberti; Sandrine Liguori; Christophe Burucoa; Gérard Couetdic; Florence Doucet-Populaire; Agnès Ferroni; Sophie Papin-Gibaud; Florence Grattard; Hélène Réglier-Poupet; Josette Raymond; Catherine Soler; Sylvie Bouchet; Sandrine Charreau; Brigitte Couzon; Isabelle Leymarie; Nicole Tavares; Mathilde Choux; Edouard Bingen; Stéphane Bonacorsi
Journal:  J Clin Microbiol       Date:  2009-08-19       Impact factor: 5.948

6.  Is the Sequenced Bordetella pertussis strain Tohama I representative of the species?

Authors:  Valérie Caro; Valérie Bouchez; Nicole Guiso
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

7.  Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.

Authors:  Sandra L Menzies; Vijay Kadwad; Lucia C Pawloski; Tsai-Lien Lin; Andrew L Baughman; Monte Martin; Maria Lucia C Tondella; Bruce D Meade
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

8.  Comparative study of different sources of pertussis toxin (PT) as coating antigens in IgG anti-PT enzyme-linked immunosorbent assays.

Authors:  Aditi Kapasi; Bruce D Meade; Brian Plikaytis; Lucia Pawloski; Monte D Martin; Sandra Yoder; Michael T Rock; Séverine Coddens; Valérie Haezebroeck; Françoise Fievet-Groyne; Garvin Bixler; Charles Jones; Stephen Hildreth; Kathryn M Edwards; Nancy E Messonnier; Maria L Tondella
Journal:  Clin Vaccine Immunol       Date:  2011-11-23

9.  Core pertussis transmission groups in England and Wales: A tale of two eras.

Authors:  Ana I Bento; Maria A Riolo; Yoon H Choi; Aaron A King; Pejman Rohani
Journal:  Vaccine       Date:  2018-02-01       Impact factor: 3.641

10.  Insertion sequences shared by Bordetella species and implications for the biological diagnosis of pertussis syndrome.

Authors:  A Tizolova; N Guiso; S Guillot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.